{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease", "BACE1", "benzochromenoquinolinones", "cholinesterase", "docking study", "inhibitors", "neuroprotective activity", "tacrine"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30720917", "DateCompleted": {"Year": "2019", "Month": "05", "Day": "28"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "04", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.1002/cbdv.201800488"], "Journal": {"ISSN": "1612-1880", "JournalIssue": {"Volume": "16", "Issue": "4", "PubDate": {"Year": "2019", "Month": "Apr"}}, "Title": "Chemistry & biodiversity", "ISOAbbreviation": "Chem Biodivers"}, "ArticleTitle": "Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.", "Pagination": {"StartPage": "e1800488", "MedlinePgn": "e1800488"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is a well-known neurodegenerative disorder affecting millions of old people worldwide and the corresponding epidemiological data emphasize the importance of the disease. As AD is a multifactorial illness, various single target directed drugs that have reached clinical trials have failed. Therefore, various factors associated with outset of AD have been considered in targeted drug discovery. In this work, various benzochromenoquinolinones were synthesized and evaluated for their cholinesterase and BACE1 inhibitory activities as well as neuroprotective and metal-chelating properties. Among the synthesized compounds, 14-amino-13-(3-nitrophenyl)-2,3,4,13-tetrahydro-1H-benzo[6,7]chromeno[2,3-b]quinoline-7,12-dione (6m) depicted the best inhibitory activity toward acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with IC<sub>50</sub> s of 0.86 and 6.03\u2005\u03bcm, respectively. Also, the compound could inhibit \u03b2-secretase 1 (BACE1) with IC<sub>50</sub> =19.60\u2005\u03bcm and showed metal chelating ability toward Cu<sup>2+</sup> , Fe<sup>2+</sup> , and Zn<sup>2+</sup> . In addition, docking study demonstrated desirable interactions of compound 6m with amino acid residues characterizing AChE, BChE, and BACE1."], "CopyrightInformation": "\u00a9 2019 Wiley-VHCA AG, Zurich, Switzerland."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, 1416753955, Iran."}], "LastName": "Mahdavi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran, University of Medical Sciences, Tehran, 1416753955, Iran."}], "LastName": "Hariri", "ForeName": "Roshanak", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy-International Campus, Iran University of Medical Sciences, Tehran, 1449614535, Iran."}], "LastName": "Mirfazli", "ForeName": "Seyedeh Sara", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran, University of Medical Sciences, Tehran, 1416753955, Iran."}], "LastName": "Lotfian", "ForeName": "Hania", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran, University of Medical Sciences, Tehran, 1416753955, Iran."}], "LastName": "Rastergari", "ForeName": "Arezoo", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, 71345-1978, Iran."}], "LastName": "Firuzi", "ForeName": "Omidreza", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, 71345-1978, Iran."}], "LastName": "Edraki", "ForeName": "Najmeh", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, 1416753955, Iran."}], "LastName": "Larijani", "ForeName": "Bagher", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran, University of Medical Sciences, Tehran, 1416753955, Iran."}, {"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, 1416753955, Iran."}], "LastName": "Akbarzadeh", "ForeName": "Tahmineh", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, 1416753955, Iran."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 1416753955, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}], "GrantList": [{"GrantID": "95-03-96-33001", "Agency": "Research Council of Tehran University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Chem Biodivers", "NlmUniqueID": "101197449", "ISSNLinking": "1612-1872"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Biphenyl Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptide Fragments"}, {"RegistryNumber": "0", "NameOfSubstance": "Picrates"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolones"}, {"RegistryNumber": "0", "NameOfSubstance": "amyloid beta-protein (23-35)"}, {"RegistryNumber": "DFD3H4VGDH", "NameOfSubstance": "1,1-diphenyl-2-picrylhydrazyl"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Biphenyl Compounds"}, {"QualifierName": ["metabolism"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Electrophorus"}, {"QualifierName": [], "DescriptorName": "Horses"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Neurons"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "PC12 Cells"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Peptide Fragments"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Picrates"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Quinolones"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "9", "Day": "20"}, {"Year": "2019", "Month": "2", "Day": "4"}, {"Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "5", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30720917", "10.1002/cbdv.201800488"]}}]}